For more than two decades, colonoscopy has been promoted as the gold standard for colorectal cancer screening. Policy makers ...

The success and popularity of GLP-1 receptor agonists (RAs) for the treatment of patients with diabetes and obesity has led to intense interest in other potential effects of treatment, including ...

A study warns that millions of people with cancer could die undiagnosed due to failures in healthcare systems.

For premenopausal women with ER-positive early breast cancer, even if chemotherapy or tamoxifen are given, OFS significantly reduces the 15-year risk of recurrence and death.

The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer—the leading cause of cancer deaths worldwide—improved long-term survival overall compared with ...

New research indicates that psychosocial factors—which influence how a person perceives, interprets, and reacts to their surroundings—do not affect an individual's risk of developing cancer. The ...

Trastuzumab deruxtecan has shown efficacy in patients with previously treated human epidermal growth factor receptor 2 (HER2)–positive advanced or metastatic breast cancer. The efficacy and safety of ...

The moment she heard that her mother, then 67, had advanced breast cancer, Stacie Dusetzina began hunting for potential treatments. A cancer policy researcher at Vanderbilt University, Dusetzina knew ...

・La détection précoce du cancer progresse fortement. ・Les tests sanguins MCED promettent un diagnostic en amont. ・Des défis éthiques et pratiques persistent pour leur adoption. Cancer : vers une ...